Search research articles
Contact Us
Filters
Showing results (1-10 of 47) with videos related to
Page
of 5
Sort By:
The American Journal of Psychiatry
|
February 1, 1983
Implications of the efficacy of thiothixene and a chlorpromazine-imipramine combination for depression in schizophrenia
R E Becker
Hospital & Community Psychiatry
|
December 1, 1988
Depression in schizophrenia
R E Becker
Brain Research Bulletin
|
August 1, 1983
Pharmacological approaches to treatment of hemiballism and hemichorea
R E Becker, H Lal
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
October 1, 1989
Clinical pharmacology of tetrahydroaminoacridine: a possible therapeutic agent Alzheimer's disease
V Kumar, R E Becker
Psychopharmacology
|
January 1, 1985
Characterization of the bupropion cue in the rat: lack of evidence for a dopaminergic mechanism
R D Blitzer, R E Becker
National Institute on Drug Abuse Research Monograph Series
|
November 1, 1975
Blood platelet monoamine oxidase activity in anergic schizophrenics
E G Shaskan, R E Becker
The American Journal of Psychiatry
|
May 1, 1977
Platelet monoamine oxidase activity in schizophrenic patients
R E Becker, E G Shaskan
Journal of Chromatography
|
January 17, 1992
Determination of heptylphysostigmine in plasma by high-performance liquid chromatography with electrochemical detection
L K Unni, R E Becker
Journal of Psychopharmacology (Oxford, England)
|
February 1, 2012
Effect of monoamine oxidase A and B inhibition on the uptake and metabolism of serotonin within serotonergic neurons of rat brain
S S Shim, R E Becker
Current Alzheimer Research
|
August 14, 2010
Why so few drugs for Alzheimer's disease? Are methods failing drugs?
R E Becker, N H Greig
Page
of 5
Search research articles
Search
Showing results (1-10 of 47) with videos related to
Sort By:
Page
of 5
The American Journal of Psychiatry
|
February 1, 1983
Implications of the efficacy of thiothixene and a chlorpromazine-imipramine combination for depression in schizophrenia
R E Becker
Hospital & Community Psychiatry
|
December 1, 1988
Depression in schizophrenia
R E Becker
Brain Research Bulletin
|
August 1, 1983
Pharmacological approaches to treatment of hemiballism and hemichorea
R E Becker, H Lal
International Journal of Clinical Pharmacology, Therapy, and Toxicology
|
October 1, 1989
Clinical pharmacology of tetrahydroaminoacridine: a possible therapeutic agent Alzheimer's disease
V Kumar, R E Becker
Psychopharmacology
|
January 1, 1985
Characterization of the bupropion cue in the rat: lack of evidence for a dopaminergic mechanism
R D Blitzer, R E Becker
National Institute on Drug Abuse Research Monograph Series
|
November 1, 1975
Blood platelet monoamine oxidase activity in anergic schizophrenics
E G Shaskan, R E Becker
The American Journal of Psychiatry
|
May 1, 1977
Platelet monoamine oxidase activity in schizophrenic patients
R E Becker, E G Shaskan
Journal of Chromatography
|
January 17, 1992
Determination of heptylphysostigmine in plasma by high-performance liquid chromatography with electrochemical detection
L K Unni, R E Becker
Journal of Psychopharmacology (Oxford, England)
|
February 1, 2012
Effect of monoamine oxidase A and B inhibition on the uptake and metabolism of serotonin within serotonergic neurons of rat brain
S S Shim, R E Becker
Current Alzheimer Research
|
August 14, 2010
Why so few drugs for Alzheimer's disease? Are methods failing drugs?
R E Becker, N H Greig
Page
of 5